Three takeaways:
1. Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said public and private stakeholders must partner on the development of two next generation shots: a pan-coronavirus vaccine (or universal vaccine) and a nasal vaccine.
2. The White House’s COVID-19 response coordinator Ashish Jha, MD, said these goals set an extremely high bar for scientists and vaccinemakers, but underscored the importance of developing more durable vaccines.
“We need vaccines that are broader and offer longer-lasting protection,” he said during the summit. “We need a vaccine that can stand up to multiple variants. Ultimately, we need vaccines that can protect us no matter what Mother Nature throws at us.”
3. It’s unclear whether the federal government would be able to fund development efforts from vaccine makers such as Moderna and Pfizer — which both had leaders attend the summit — as Congress has failed to pass a $10 billion COVID-19 funding deal to support pandemic response activities, U.S. News reported.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.